Articles from BIOTECH Patent News (January 1, 2000)

1-53 out of 53 article(s)

Title	Type	Words
[2] Incyte obtains United States patent.	Brief Article	50
Abgenix and Elan enter Xenomouse technology collaboration to generate fully human antibody therapy for neurological diseases.	Brief Article	317
Abgenix and Gliatech enter Xenomouse technology collaboration.	Brief Article	327
Advanced Tissue Sciences obtains United States patent.	Brief Article	82
AdVec obtains United States patent.	Brief Article	31
Affymetrix and Novartis sign Genechip Easyaccess Silver agreement.	Brief Article	278
Allelix obtains United States patent.		28
Asahi obtains United States patent.	Brief Article	81
Bristol-Myers Squibb obtains United States patent.	Brief Article	28
British grant of cloning patent supports PPL's programs.	Brief Article	468
Brown University applies for patent.	Brief Article	33
Burnham Institute applies for patent.	Brief Article	28
Cambridge University applies for patent.	Brief Article	33
Carnegie Mellon applies for patent.	Brief Article	31
Chiesi and Epigenesis enter license and development agreement for antisense oligonucleotide treatment of asthma.	Brief Article	532
Chiron applies for patent.	Brief Article	30
Collateral Therapeutics announces issuance of United States patent for angiogenic growth factor gene Vegf-145.	Brief Article	511
Cornell applies for patent.	Brief Article	40
Cortex' ampakines increase neurotrophin expression.	Brief Article	611
DeKalb obtains United States patent.	Brief Article	136
DuPont applies for patent.	Brief Article	39
Entremed announces cardiovascular research collaboration with Children's Hospital, Boston.		594
Federal Appeals Court affirms Pioneer's right to patent seeds and plants.	Brief Article	254
Genentech applies for patent.	Brief Article	34
Genset and Whitehead Institute sign license and research agreements in the field of obesity and diabetes.	Brief Article	609
Genzyme applies for patent.	Brief Article	40
Hoechst Marion Roussel obtains United States patent.	Brief Article	69
Idun licenses research rights to its apoptosis technology exclusively to Becton Dickinson Biosciences.	Brief Article	430
Immunomedics patents new '2-Punch' therapy of cancer with bispecific fusion proteins.	Brief Article	466
Incyte obtains United States patent.	Brief Article	47
Institute for Molecular & Cell Biology applies for patent.	Brief Article	35
Johns Hopkins applies for patent.	Brief Article	34
Laboratoire European de Biotechnologie obtains United States patent.	Brief Article	58
Lexicon Genetics grants sublicense to Roche Bioscience under positive-negative selection and isogenic DNA technology.	Brief Article	500
Life Technologies applies for patent.	Brief Article	32
LifeCell obtains United States patent.	Brief Article	101
Massachusetts Institute of Technology obtains United States patent.	Brief Article	56
Medigene applies for patent.	Brief Article	25
Novo Nordisk obtains United States patent.	Brief Article	34
Oregon Health Sciences University obtains United States patent.	Brief Article	135
OSI Pharmaceuticals licenses Cyanamid's yeast Gpcr technology in patent cross-licensing agreement.	Brief Article	596
Patent awarded to Integra Lifesciences for Duragen dural graft matrix technology.	Brief Article	286
Protein Design announces agreement with Celltech Chiroscience for antibody patents.	Brief Article	370
Schering applies for patent.	Brief Article	28
Scripps Research Institute applies for patent.	Brief Article	42
SmithKline Beecham applies for patent.	Brief Article	31
Smithkline Beecham obtains United States patent.	Brief Article	62
Targeted Genetics licenses key gene expression technology to GTI/Systemix.	Brief Article	1051
Thm Biomedical receives patent for a method and device for the reconstruction of articular cartilage.	Brief Article	312
Visible Genetics receives notice of patent suit.	Brief Article	185
Vysis to defend patent licensed to Gen-Probe.	Brief Article	584
Whitehead Institute obtains United States patent.	Brief Article	68
ZymoGenetics obtains United States patent.	Brief Article	163